lymphocyte antigen cd20 theoretical model protein expressed the surface cells anti monoclonal antibody drugs

navigate by keyword : pdb1s8b cd20 cluster differentiation blymphocyte lymphocyte bcell antigen ms4a1 surface lymphoma leukemia immunohistochemistry histology antibody rituximab obinutuzumab ibritumab tiuxetan veltuzumab lupus rheumatoid arthritis multiple sclerosis structure peptide protein amino acid molecule polypeptide polymer atoms science scientific disease health molecular model rendering illustration

B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs Royalty Free Stock Photo
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs Royalty Free Stock Photo
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs Royalty Free Stock Photo
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs Royalty Free Stock Photo
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs Royalty Free Stock Photo
   
   
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
   
   
   
   
   
   
   
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs include rituximab, ibritumab tiuxetan, ofatumumab, obinutuzumab and tositumomab. 3D rendering based on protein data bank entry 1s8b. Cartoon representation with secondary structure coloring (green sheets, red helices

Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.